Author

B. Delmas

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Approach:deep learning· 1 Organism:human· 1 Assay:long-read sequencing· 1 Assay:proteomics· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

A. Roussel· 2 shared B. Da Costa· 2 shared J. Morel· 2 shared N. Lejal· 2 shared Q. Nevers· 2 shared A. Ballandras-Colas· 1 shared A. Chenal· 1 shared A. Dogliani· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. Roussel

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genome sequences of equine influenza A subtype H3N8 viruses by long read sequencing and functional characterization of the PB1-F2 virulence factor of A/equine/Paris/1/2018

L. Kleij, E. Bruder, D. Raoux-Barbot, N. Lejal, Q. Nevers, C. Deloisy, B. Da Costa, L. Legrand, E. Barrey, A. Chenal, S. Pronost, B. Delmas, S. Dhorne-Pollet

This study uses long-read sequencing to characterize equine influenza A H3N8 viruses, identifying antigenic drift and a virulence-enhancing PB1-F2 protein variant.

bioRxiv · Oct 25, 2023 · PreprintMicrobiology

Antiviral activity of intracellular nanobodies targeting the influenza virus RNA-polymerase core

M. Bessonne, J. Morel, Q. Nevers, A. Ballandras-Colas, M. Grange, A. Roussel, T. Crepin, B. Delmas

This paper identifies an intracellular nanobody that inhibits influenza A virus RNA-polymerase by blocking PA-PB1 dimer nuclear import, showing potential for antiviral development.

bioRxiv · Aug 31, 2023Microbiology

Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals

S. Thebault, N. Lejal, A. Dogliani, A. Donchet, A. Urvoas, M. Valerio-Lepiniec, M. Lavie, C. Baronti, F. Touret, B. da Costa, C. Bourgon, A. Fraysse, A. Saint-Albin-Deliot, J. Morel, B. Klonjkowski, , B. Delmas

This paper identifies biosynthetic proteins (Reps) that bind the SARS-CoV-2 spike RBD and neutralize the virus, including variants, with high potency and stability.

bioRxiv · May 10, 2022Microbiology